NIO shares fell -2.19% during regular trading on Tuesday, erasing an overnight pop to trade near $4.91 after closing the prior session at $5.02. The primary catalyst was the U.
SNDK is down approximately -11.5% during Tuesday's regular session, extending a multi-session rout that has now erased over 25% from its all-time high near $2,354. The primary catalyst is a global memory chip selloff triggered by Samsung's blowout Q2 results — operating profit surged 1,810% YoY, but Samsung shares fell sharply in Seoul as investors executed a classic "sell the news" reaction.
Vishay Intertechnology shares have declined approximately 25.7% over the last 30 days, falling from $57.20 to $42.49, driven primarily by a large dilutive equity offering. The company priced a $750 million public offering of 15 million common shares at $50 per share on June 29, with underwriters exercising the full overallotment option, bringing total net proceeds to roughly $830 million.
Corcept Therapeutics shares surged approximately 28.3% over the last 30 days, climbing from $72.62 to $93.16, driven by the resubmission of its New Drug Application for relacorilant in Cushing's syndrome. The stock has posted an extraordinary quarterly gain of roughly 123.5%, reflecting a powerful rally that began in early May following the Lifyorli approval in ovarian cancer and accelerating through June.
Birkenstock shares have recovered approximately 8% over the past 30 days, rebounding from mid-May lows near $31 to trade around $45.84, though the stock remains below earlier 2026 highs. The company completed a €900 million debt refinancing in June 2026, lowering its interest coupon from 5.25% to 4.50% while extending maturities to 2033 and authorizing up to $500 million in additional share repurchases.
Wayfair shares surged approximately 34.5% over the past 30 days, climbing from $68.35 on June 5 to $91.94 as of July 7, 2026. The rally was fueled by a combination of analyst upgrades, positive e-commerce data, AI-driven retail optimism, and the company's expanding physical store footprint.
Dutch Bros (BROS) shares surged approximately 22.4% over the past 30 days, climbing from $55.52 on June 5, 2026, to $67.94 on July 7, 2026. The rally marks a sharp recovery from a May sell-off that followed the company's first-quarter earnings report, with the stock now up more than 28% for the quarter.
MGM shares have pulled back modestly over the last 30 days, declining about 1.3% from $47.51 to $46.88, reflecting a period of consolidation. The stock remains up roughly 27.5% over the past quarter, driven by a powerful rally in late May that pushed prices from the mid-$30s to above $43.
CRNX shares surged +98.69% in pre-market trading on Tuesday, reaching $83.51 after Vertex Pharmaceuticals announced a definitive agreement to acquire the company for $85 per share in cash. The all-cash deal values Crinetics at approximately $10 billion in equity, representing a 102% premium to Monday's closing price of $42.03.
Rivian Automotive RIVN shares fell 10.00% in premarket trading Tuesday, dropping to $16.77 from Monday's close of $18.63. The primary catalyst is Rivian's announcement of an underwritten public offering of 75 million shares of common stock, raising concerns about shareholder dilution.
Western Digital WDC shares fell 6.55% in premarket trading Tuesday, dropping to $539.66 from Monday's close of $577.46. The decline stems from a broad memory and storage sector selloff triggered by a "sell-the-news" reaction to Samsung's preliminary quarterly earnings.
Applied Materials AMAT shares fell 5.73% in premarket trading Tuesday, dropping to $558.84 from Monday's close of $592.79. The decline is tied to a broader semiconductor and memory-equipment selloff triggered by a "sell-the-news" reaction to Samsung's preliminary earnings.
Micron Technology MU shares dropped roughly 6.03% in premarket trading Tuesday, falling to $925.37 from a prior close near $984.75. The decline followed a broad semiconductor selloff triggered by a "sell-the-news" reaction to Samsung's preliminary quarterly results.
Analysts expect earnings per share of $0.49 for the third quarter of fiscal 2026. Revenue consensus stands at approximately $164.5 million, reflecting modest year-over-year growth.
Penguin Solutions, Inc. is scheduled to report third quarter fiscal 2026 results after market close on July 7, 2026.
CVS Health shares have gained approximately 6.4% over the last 30 days, building on a broader quarterly rally of roughly 30.5%. The company's June 2026 launch of a comprehensive GLP-1 support program across its 9,000 pharmacies has drawn analyst upgrades and renewed investor attention.
KELYB fell -9.14% during Monday's regular session, dropping to $19.99 from a previous close of $22.00 on July 2. The decline extends a sharp reversal from last week's multi-day surge that had pushed the stock from ~$18 to an intraweek high of $23.40.
BLMN shares dropped -8.97% during Monday's regular session, falling from a previous close of $8.70 on July 2 to $7.92, extending a multi-week decline from post-earnings highs near $8.56. The sell-off follows the July 1 disclosure that Chief Human Resources Officer Jessica Mitory resigned effective August 17, adding executive uncertainty to an already cautious sentiment around the casual dining operator.
APPS shares fell -8.18% during Monday's regular trading session, dropping from a previous close of $12.71 to approximately $11.67, with an intraday low of $11.86. The decline follows a massive rally that propelled the stock from a 52-week low of $2.74 in April to a recent peak of $13.60, signaling profit-taking after the stock became technically overbought with an RSI above 82.
AKTS plunged -16.28% during Monday's regular trading session, falling from Friday's close of $31.76 to $26.59, erasing a significant portion of recent gains. The sell-off follows a powerful rally that saw the stock surge over +40% in the prior two weeks, hitting a new 52-week high above $34, suggesting profit-taking as the primary driver.